Subscribe to our RSS Feed Chinese Medicine Times Facebook Fan Page Chinese Medicine Times Twitter Page Chinese Medicine Times Linkedin Page
Chinese Medicine Times - eJournal

DNA based identification of medicinal materials in Chinese patent medicines

Source: http://www.ncbi.nlm.nih.gov/pubmed/23233877

Abstract

Chinese patent medicines (CPM) are highly processed and easy to use Traditional Chinese Medicine (TCM). The market for CPM in China alone is tens of billions US dollars annually and some of the CPM are also used as dietary supplements for health augmentation in the western countries. But concerns continue to be raised about the legality, safety and efficacy of many popular CPM. Here we report a pioneer work of applying molecular biotechnology to the identification of CPM, particularly well refined oral liquids and injections. What's more, this PCR based method can also be developed to an easy to use and cost-effective visual chip by taking advantage of G-quadruplex based Hybridization Chain Reaction. This study demonstrates that DNA identification of specific Medicinal materials is an efficient and cost-effective way to audit highly processed CPM and will assist in monitoring their quality and legality.

Latest Articles and News


   Print-friendly Version

Payment methods

| | | |

This site and contents are copyright 2006 - 2012

is the trade name of CMT Integrated Health Ltd, , , , , . Registered in England and Wales No. 6528121. VAT No. GB 941 4574 19.